Of note, ADAM10/17/19 overexpression compensated for BRG1 depletion to restore CRC cell migration and invasion indicating that BRG1 may be a common mediator of ADAM induction in malignant CRC cells. Here, ADAM10 is linked to colorectal carcinoma.